The Department of Health and Human Services, Office of Inspector General (OIG) recently issued a favorable advisory opinion (Advisory...
Reed Smith LLP
On May 5, the Trump Administration issued a pair of executive orders that could signal big changes for the drug industry and health...
Shortly after Connecticut’s 2023 legislative session kicked off, Governor Ned Lamont announced a series of policy initiatives aimed at...
On April 18, 2023, the U.S. Department of Health and Human Services (“HHS”) announced its plan to maintain access to COVID-19 vaccines...
On April 7, 2023, only minutes apart, two federal district courts issued rulings on cases challenging the Food and Drug Administration’s...
[Note, this is Part 3 in an ongoing series of posts exploring substantive aspects of the Consolidated Appropriations Act, 2023 (P.L....
On June 7, 2022, the Federal Trade Commission (FTC) announced that it would conduct an inquiry into the competitive impact of contracting...
The House Energy and Commerce Committee seems poised to make substantial changes to the Food and Drug Administration’s (“FDA’s”)...
In 2010, the Affordable Care Act (ACA) directed the Secretary of Health and Human Services to issue regulations to establish an...